REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto del Sistema Nervioso del Oriente S.A. Isnor S.A. (Colombia)

Main Activities: General Medical and Surgical Hospitals
Full name: Instituto del Sistema Nervioso del Oriente S.A. Isnor S.A. Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto del Sistema Nervioso del Oriente S.A. Isnor S.A. is an enterprise based in Colombia. Its main office is in Bucaramanga. It operates in the General Medical and Surgical Hospitals industry. It was incorporated on August 31, 1987. It currently has a total number of 97 (2024) employees. There was a net sales revenue increase of 25.21% reported in Instituto del Sistema Nervioso del Oriente S.A. Isnor S.A.’s latest financial highlights for 2023. Its total assets grew by 16.82% over the same period. In, 2023, the company’s net profit margin increased by 2.99%.

Headquarters
Cl. 50 # 23-100
Bucaramanga; Santander;

Contact Details: Purchase the Instituto del Sistema Nervioso del Oriente S.A. Isnor S.A. report to view the information.

Website: http://www.clinicaisnor.com

Basic Information
Total Employees:
Purchase the Instituto del Sistema Nervioso del Oriente S.A. Isnor S.A. report to view the information.
Outstanding Shares:
Purchase the Instituto del Sistema Nervioso del Oriente S.A. Isnor S.A. report to view the information.
Incorporation Date:
August 31, 1987
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto del Sistema Nervioso del Oriente S.A. Isnor S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
25.21%
Total operating revenue
25.21%
Operating profit (EBIT)
77.3%
EBITDA
53.62%
Net Profit (Loss) for the Period
122.9%
Total assets
16.82%
Total equity
14.84%
Operating Profit Margin (ROS)
3.2%
Net Profit Margin
2.99%
Return on Equity (ROE)
6.14%
Debt to Equity Ratio
-8.63%
Quick Ratio
0.12%
Cash Ratio
0.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?